| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Acquisition of business, net of cash acquired of 541 | 1,773 | 1,773 |
| Net cash provided by investing activities | 16,259 | 11,067 |
| Proceeds from exercise of stock options | 417 | 403 |
| Proceeds from issuance of common stock under employee stock purchase plan | 134 | 134 |
| Net cash provided by financing activities | 551 | 537 |
| Net decrease in cash and cash equivalents | -14,911 | -12,659 |
| Cash and cash equivalents at beginning of period | 27,884 | - |
| Cash and cash equivalents at end of period | 12,973 | - |
MAXCYTE, INC. (MXCT)
MAXCYTE, INC. (MXCT)